Eyenuk Inc Receives Health Canada Approval For Eyeartв ў A Eyenuk’s mdsap audit covered the relevant quality management system requirements of iso 13485:2003, the u.s. food and drug administration and health canada. about diabetic retinopathy. Immediate, fully automated, on site diabetic retinopathy screening report in 60 seconds. no human grading needed. watch video experience eyeart eyeart® ai eye screening system eyeart is the first and only fda cleared ai technology for autonomous.
Eyenuk Receives Health Canada Approval For Eyeart Eyenuk, inc. receives health canada approval for eyeart™, an ai enabled cloud based automated diabetic retinopathy screening software march 8, 2018 march 8, 2018. Eyenuk received fda clearance to use an additional retinal camera for the detection of diabetic retinopathy (dr) that is easier to use and make it easier for primary care clinics to adopt the technology. according to a news release, the company can now use the topcon nw400 retinal camera with its eyeart ai system to automatically detect. This week, eyenuk received fda clearance to use the topcon nw400 retinal camera with its eyeart ai system to automatically detect diabetic retinopathy. joining us to discuss this clearance is dr. kaushal solanki, founder and ceo of eyenuk. thank you so much for joining us today. About eyenuk, inc. eyenuk, inc. is a global artificial intelligence (ai) medical technology and services company and the leader in real world ai eye screening for autonomous disease detection and.
Comments are closed.